Status: Recruiting
A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)
This study is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy and safety of D-2570 in the treatment of active systemic lupus erythematosus.
Participants needed: 120
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: InventisBio Co., LtdUpdated: Apr 24, 2026Locations: 1
Eligibility criteria
The patient voluntarily participates in this study after full informed consent. [+4]
History of infection as defined in the protocol. [+2]